Integrated DIA Proteomics and Lipidomics Analysis on Non-small Cell Lung Cancer Patients with TCM Syndromes

Overview

Journal Chin Med

Publisher Biomed Central

Specialty Biomedical Engineering

Date 2021 Nov 28

PMID 34838074

Citations 3

Authors

Song Cang

Ran Liu

Wei Jin

Qi Tang

Wanjun Li

Kunqian Mu

Pengfei Jin

Kaishun Bi

Qing Li

Affiliations

Soon will be listed here.

Abstract

Background: Lung cancer remains the leading cause of mortality from malignant tumors, non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer cases, and individualized diagnosis and treatment is an effective trend. The individual characteristics of different traditional Chinese medicine (TCM) syndromes of NSCLC patients may be revealed by highly specific molecular profiles.

Methods: In this study, 10 NSCLC patients with Qi deficiency and Yin deficiency (QDYD) syndrome and 10 patients with Qi deficiency of lung-spleen (QDLS) syndrome in TNM stage III-IV as well as 10 healthy volunteers were enrolled. Aiming at the varied syndromes of NSCLC patients with "Yin deficiency" as the main difference, a proteomics research based on data-independent acquisition (DIA) was developed. Of the dysregulated proteins in NSCLC patients, lipid metabolism was significantly enriched. Thereafter, nontargeted lipidomics research based on UPLC-Q-TOF/MS was performed in 16 patients, with 8 individuals randomly selected from each syndrome group. Furthermore, the considerably different characteristics between the syndromes and pathological mechanisms of NSCLC were screened by statistical and biological integrations of proteomics and lipidomics and the differential metabolic pathways of the two similar syndromes were further explored. Besides, lipids biomarkers were verified by a clinically used anticancer Chinese medicine, and the level of key differential proteins in the two syndromes was also validated using ELISA.

Results: The results showed that glycerophospholipid metabolism, sphingolipid metabolism, glycolipid metabolism, and primary bile acid biosynthesis were altered in NSCLC patients and that glycerophospholipid metabolism was significantly changed between the two syndromes in lipidomics analysis. Among the proteins and lipids, ALDOC and lysophosphatidylcholine (LPCs) were revealed to have a strong relationship by statistical and biological integration analysis, and could effectively distinguish QDLS and QDYD syndromes. Notably, the patients with different syndromes had the most typical metabolic patterns in glycerophospholipid metabolism and glycolysis, reflecting the differences in the syndromes dominated by "Yin deficiency".

Conclusions: ALDOC and LPCs could be employed for the differentiation of NSCLC patients with QDLS and QDYD syndromes, and "Yin deficiency" might be associated with glycerophospholipid metabolism and glycolysis pathway. The results provided a theoretical basis for "Syndrome differentiation" in TCM diagnosis. Moreover, the developed integrated strategy could also provide a reference for individualized diagnosis and treatment of other diseases.

Citing Articles

Untargeted metabolomics combined with pseudotargeted lipidomics revealed the metabolite profiles of blood-stasis syndrome in type 2 diabetes mellitus.

Liu L, Liang Y, Liu X, Wang H, Qi Y, Wang M Heliyon. 2024; 10(20):e39554.

PMID: 39498030 PMC: 11533630. DOI: 10.1016/j.heliyon.2024.e39554.

Acute-phase plasma proteomics of rabbit lung VX2 tumors treated by image-guided microwave ablation.

Cheng L, Peng J, Li S, Bie Z, Li X Front Oncol. 2024; 14:1435256.

PMID: 39252952 PMC: 11381224. DOI: 10.3389/fonc.2024.1435256.

Differential proteomic of plasma provides a new perspective on scientific diagnosis and drug screening for dampness heat diarrhea in calves.

Yan Z, Zhang K, Wang G, Wang L, Zhang J, Qiu Z Front Vet Sci. 2022; 9:986329.

PMID: 36204290 PMC: 9530945. DOI: 10.3389/fvets.2022.986329.

References

An T, Qin S, Sun D, Huang Y, Hu Y, Li S . Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer. Proteomics. 2019; 19(12):e1800160. DOI: 10.1002/pmic.201800160. View

Cai F, Zhu Q, Miao Y, Shen S, Su X, Shi Y . Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2. J Cancer Res Clin Oncol. 2016; 143(1):59-69. DOI: 10.1007/s00432-016-2250-0. View

Lu C, Zhang J, He S, Wan C, Shan A, Wang Y . Increased α-tubulin1b expression indicates poor prognosis and resistance to chemotherapy in hepatocellular carcinoma. Dig Dis Sci. 2013; 58(9):2713-20. DOI: 10.1007/s10620-013-2692-z. View

Carrasco S, Merida I . Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci. 2006; 32(1):27-36. DOI: 10.1016/j.tibs.2006.11.004. View

Gao S, Chen L, Wang P, Liu L, Chen Z . MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG. Biomed Res Int. 2014; 2014:756347. PMC: 4122139. DOI: 10.1155/2014/756347. View

van der Veen J, Kennelly J, Wan S, Vance J, Vance D, Jacobs R . The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017; 1859(9 Pt B):1558-1572. DOI: 10.1016/j.bbamem.2017.04.006. View

Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F . Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002; 296(3):580-3. DOI: 10.1016/s0006-291x(02)00920-8. View

Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R . LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. J Exp Clin Cancer Res. 2019; 38(1):95. PMC: 6385475. DOI: 10.1186/s13046-019-1092-4. View

Lin S, Wang T, Xu H, Zhang X, Wang Q, Liu R . A systemic combined nontargeted and targeted LC-MS based metabolomic strategy of plasma and liver on pathology exploration of alpha-naphthylisothiocyanate induced cholestatic liver injury in mice. J Pharm Biomed Anal. 2019; 171:180-192. DOI: 10.1016/j.jpba.2019.04.009. View

10.

Zou J, Ma X, Zhang G, Shen L, Zhou L, Yu Y . Evaluation of the change in sphingolipids in the human multiple myeloma cell line U266 and gastric cancer cell line MGC-803 treated with arsenic trioxide. J Chromatogr B Analyt Technol Biomed Life Sci. 2015; 1004:98-107. DOI: 10.1016/j.jchromb.2015.09.015. View

11.

Chiu K, Chang Y, Wu Y, Lee S, Liao P . Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J Proteome Res. 2010; 10(3):1110-25. DOI: 10.1021/pr1008724. View

12.

Chae H, Pel P, Cho J, Kim Y, An C, Huh J . Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by transcriptional regulation of LDLR via SREBP2. J Ethnopharmacol. 2021; 278:114265. DOI: 10.1016/j.jep.2021.114265. View

13.

Zadra G, Photopoulos C, Loda M . The fat side of prostate cancer. Biochim Biophys Acta. 2013; 1831(10):1518-32. PMC: 3766375. DOI: 10.1016/j.bbalip.2013.03.010. View

14.

Chi P, Liu W, Chen H, Zhang J, Lin Y, Zheng X . High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma. PLoS One. 2014; 9(3):e91080. PMC: 3953329. DOI: 10.1371/journal.pone.0091080. View

15.

Chen Q, Fei J, Wu L, Jiang Z, Wu Y, Zheng Y . Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients. Oncol Lett. 2012; 2(4):693-699. PMC: 3406412. DOI: 10.3892/ol.2011.302. View

16.

Jantscheff P, Schlesinger M, Fritzsche J, Taylor L, Graeser R, Kirfel G . Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo. Mol Cancer Ther. 2011; 10(1):186-97. DOI: 10.1158/1535-7163.MCT-10-0474. View

17.

Gu L, Saha S, Thomas J, Kaur M . Targeting cellular cholesterol for anticancer therapy. FEBS J. 2019; 286(21):4192-4208. DOI: 10.1111/febs.15018. View

18.

Zhang L, Chen P, Yang S, Li G, Bao W, Wu P . CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator. Oncol Lett. 2016; 12(3):1849-1853. PMC: 4998128. DOI: 10.3892/ol.2016.4810. View

19.

Cruz P, Mo H, McConathy W, Sabnis N, Lacko A . The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol. 2013; 4:119. PMC: 3782849. DOI: 10.3389/fphar.2013.00119. View

20.

Cheng M, Bhujwalla Z, Glunde K . Targeting Phospholipid Metabolism in Cancer. Front Oncol. 2017; 6:266. PMC: 5187387. DOI: 10.3389/fonc.2016.00266. View